2023 Patient Access: State Legal and Regulatory Environment Survey Report
Given the dynamic nature of state gove
rnment activity we sought to validate the following:
- Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters.
- There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies.
- Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle.
Full Report
Curatio Scientia Advisors releases the “2023 Patient Access: State Legal and Regulatory Environment Survey”
Given the dynamic nature of state government activity we sought to validate the following:
- Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters.
- There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies.
- Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle.